Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lists of potential infringers

Ok. Rephrasing.

Has it been communicated anywhere that targets have been split up?

Is territory somehow implied by the approval of the joint plan?

If territory is not defined then how do the licensing agents proceed given the uncertainties?

FWIW-I am also interested in who the 3rd PDS member is and what it'll mean to shareholders going forward.

Share
New Message
Please login to post a reply